Alpha-1-Antitrypsin (A1AT) Proteotyping by LC-MS/MS.

Area of Science:

• Proteomics
• Mass Spectrometry
• Clinical Diagnostics

Background:

• Alpha-1-antitrypsin (A1AT) deficiency diagnosis relies on serum protein quantitation and allelic variant determination.
• Current phenotyping and genotyping methods have limitations.
• Mass spectrometry offers a powerful alternative for protein and peptide analysis.

Purpose of the Study:

• To introduce and validate a proteomic method, termed proteotyping, for detecting common A1AT deficiency alleles (S and Z).
• To evaluate the utility of mass spectrometry in identifying specific A1AT allelic variants.

Main Methods:

• Proteotyping involves trypsin digestion of A1AT followed by tandem mass spectrometry.
• The method detects mass differences in specific peptides resulting from S and Z mutations compared to wild-type (M) alleles.
• Qualitative analysis of peptide patterns is performed.

Main Results:

• Proteotyping successfully differentiates peptides from S and Z alleles from those of wild-type M alleles based on mass.
• The method identifies the presence of deficiency alleles by analyzing characteristic peptide mass shifts.
• Combined with immunoassay quantitation, proteotyping allows accurate assessment of A1AT deficiency alleles.

Conclusions:

• Proteotyping is a viable mass spectrometry-based approach for identifying common A1AT deficiency alleles.
• This method provides an alternative diagnostic tool for A1AT deficiency.
• The technique leverages mass differences in digested peptides for accurate allele detection.